Oxmax RSS Authorised This medicine is authorised for use in the European Union Hemoglobin betafumaril (bovine) Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Oxmax Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Oxmax Active substance Hemoglobin betafumaril (bovine) International non-proprietary name (INN) or common name Hemoglobin betafumaril (bovine) Pharmacotherapeutic groupBlood substitutes and plasma protein fractions Authorisation details EMA product number EMEA/V/C/005132 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for OxmaxAdopted Reference Number: EMA/CVMP/374571/2023 English (EN) (123.31 KB - PDF)First published: 08/09/2023 View News on Oxmax Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 202308/09/2023 This page was last updated on 23/05/2024 Share this page